Cargando…

Aldehyde dehydrogenase 2 and NOD-like receptor thermal protein domain associated protein 3 inflammasome in atherosclerotic cardiovascular diseases: A systematic review of the current evidence

Inflammation and dyslipidemia underlie the pathological basis of atherosclerosis (AS). Clinical studies have confirmed that there is still residual risk of atherosclerotic cardiovascular diseases (ASCVD) even after intense reduction of LDL. Some of this residual risk can be explained by inflammation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Xue-yun, Yue, Xiao-lin, Xu, You-shun, Jiang, Mei, Li, Rui-jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996072/ https://www.ncbi.nlm.nih.gov/pubmed/36910525 http://dx.doi.org/10.3389/fcvm.2023.1062502

Ejemplares similares

Aldehyde dehydrogenase 2 inhibits inflammatory response and regulates atherosclerotic plaque
por: Pan, Chang, et al.
Publicado: (2016)

NLRP3 Inflammasome Signaling as a Link Between HIV-1 Infection and Atherosclerotic Cardiovascular Disease
por: Mullis, Caroline, et al.
Publicado: (2020)

Targeting the NOD-, LRR- and Pyrin Domain-Containing Protein 3 (NLRP3) Inflammasome in Psoriasis and Fatigue
por: Seguro, Charmaine Kue, et al.
Publicado: (2022)

Defective Protein Catabolism in Atherosclerotic Vascular Inflammation
por: Miyazaki, Takuro, et al.
Publicado: (2017)

Remnant cholesterol and atherosclerotic cardiovascular disease: Metabolism, mechanism, evidence, and treatment
por: Wang, Kexin, et al.
Publicado: (2022)

Alcohol dehydrogenase and aldehyde dehydrogenase in malignant neoplasms
por: Orywal, Karolina, et al.
Publicado: (2016)

The Spectrum of B Cell Functions in Atherosclerotic Cardiovascular Disease
por: Smeets, Diede, et al.
Publicado: (2022)

Association between Nod-like receptor protein 3 inflammasome and gouty nephropathy
por: Zhang, Yan-Zi, et al.
Publicado: (2020)

Association Between Periodontal Disease and Atherosclerotic Cardiovascular Diseases: Revisited
por: Zardawi, Faraedon, et al.
Publicado: (2021)

Atherosclerotic cardiovascular diseases in inflammatory bowel diseases: to the heart of the issue
por: Gabbiadini, Roberto, et al.
Publicado: (2023)

The role of Nod-like receptor protein 3 inflammasome activated by ion channels in multiple diseases
por: Xu, Xiaolin, et al.
Publicado: (2022)

NLRP3 inflammasome: The rising star in cardiovascular diseases
por: Zheng, Yidan, et al.
Publicado: (2022)

ALDH1A3 Is the Key Isoform That Contributes to Aldehyde Dehydrogenase Activity and Affects in Vitro Proliferation in Cardiac Atrial Appendage Progenitor Cells
por: Puttini, Stefania, et al.
Publicado: (2018)

E3 Ubiquitin Ligases as Immunotherapeutic Target in Atherosclerotic Cardiovascular Disease
por: Poels, Kikkie, et al.
Publicado: (2020)

Paeonol for the Treatment of Atherosclerotic Cardiovascular Disease: A Pharmacological and Mechanistic Overview
por: Wu, Min, et al.
Publicado: (2021)

Atherosclerotic Cardiovascular Disease Risk and Lipid-Lowering Therapy Requirement in China
por: Bi, Lei, et al.
Publicado: (2022)

The interplay between nonalcoholic fatty liver disease and atherosclerotic cardiovascular disease
por: Finney, Alexandra C., et al.
Publicado: (2023)

Common variable immunodeficiency—an independent risk factor for atherosclerotic cardiovascular diseases
por: Mattila, Juho, et al.
Publicado: (2023)

Evidence That the C-Terminal Domain of a Type B PutA Protein Contributes to Aldehyde Dehydrogenase Activity and Substrate Channeling
por: Luo, Min, et al.
Publicado: (2014)

NOD-Like Receptor Protein 3 Inflammasome Priming and Activation in Barrett’s Epithelial Cells
por: Nadatani, Yuji, et al.
Publicado: (2016)

Differential effects of organic nitrates on arterial diameter among healthy Japanese participants with different mitochondrial aldehyde dehydrogenase 2 genotypes: randomised crossover trial
por: Sakata, Satoko, et al.
Publicado: (2011)

Thermal Effect on Heat Shock Protein 70 Family to Prevent Atherosclerotic Cardiovascular Disease
por: Nagai, Masayo, et al.
Publicado: (2023)

Protein Phosphatase 2A Deficiency in Macrophages Increases Foam Cell Formation and Accelerates Atherosclerotic Lesion Development
por: Li, Rui, et al.
Publicado: (2022)

Alcohol Consumption, Aldehyde Dehydrogenase 2 Gene Polymorphisms, and Cardiovascular Health in Korea
por: Shin, Min-Jeong, et al.
Publicado: (2017)

Mitochondrial aldehyde dehydrogenase and cardiac diseases
por: Chen, Che-Hong, et al.
Publicado: (2010)

SAXS fingerprints of aldehyde dehydrogenase oligomers
por: Tanner, John J.
Publicado: (2015)

Aldehyde Dehydrogenase, Liver Disease and Cancer
por: Wang, Wenjun, et al.
Publicado: (2020)

Aldehyde Dehydrogenase 1 in Gastric Cancer
por: Wang, Ling, et al.
Publicado: (2022)

Reduced aldehyde dehydrogenase expression in preeclamptic decidual mesenchymal stem/stromal cells is restored by aldehyde dehydrogenase agonists
por: Kusuma, Gina D., et al.
Publicado: (2017)

Metabolomics profile and 10-year atherosclerotic cardiovascular disease (ASCVD) risk score
por: Dehghanbanadaki, Hojat, et al.
Publicado: (2023)

Enrichment of Chemical Libraries Docked to Protein Conformational Ensembles and Application to Aldehyde Dehydrogenase 2
por: Wang, Bo, et al.
Publicado: (2014)

The relationships between cholesterol crystals, NLRP3 inflammasome, and coronary atherosclerotic plaque vulnerability in acute coronary syndrome: An optical coherence tomography study
por: Xue, Chao, et al.
Publicado: (2022)

Prognostic values of aldehyde dehydrogenase 1 isoenzymes in ovarian cancer
por: Ma, Yu-mei, et al.
Publicado: (2016)

The mechanism behind activation of the Nod-like receptor family protein 3 inflammasome in Parkinson’s disease
por: Wang, Jing, et al.
Publicado: (2021)

Glucose Fluctuations Aggravate Myocardial Fibrosis via the Nuclear Factor-κB-Mediated Nucleotide-Binding Oligomerization Domain-Like Receptor Protein 3 Inflammasome Activation
por: Zhang, Zhen-Ye, et al.
Publicado: (2022)

Glycemia and Atherosclerotic Cardiovascular Disease: Exploring the Gap Between Risk Marker and Risk Factor
por: Nahmias, Avital, et al.
Publicado: (2020)

Effect of PCSK9 on atherosclerotic cardiovascular diseases and its mechanisms: Focus on immune regulation
por: Ma, Minglu, et al.
Publicado: (2023)

Effect of causative genetic variants on atherosclerotic cardiovascular disease in heterozygous familial hypercholesterolemia patients
por: Matta, Anthony, et al.
Publicado: (2023)

Effects of norepinephrine on plaque hypoxia in atherosclerotic rabbits
por: Wang, Jia-Yu, et al.
Publicado: (2023)

The Genetics of Alcohol Metabolism: Role of Alcohol Dehydrogenase and Aldehyde Dehydrogenase Variants
por: Edenberg, Howard J.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_kqrn3qch9tt2r700blj17e2p4t